Gaining Momentum, Biodexa is Advancing Two Recent Acquisitions Through the Clinic
November 21, 2024
Oncocyte Corporation Announces Pricing of Public Offering of Common Stock and Warrants
April 13, 2022
Related Post
-
-
Genprex Signs Exclusive License to Additional Gene Therapy Technologies with the University of Michigan for the Treatment of Lung Cancer
November 20, 2024
-
Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS mutated mCRC
November 19, 2024
-
Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger
November 11, 2024